Table of Content

Contents

1. Executive Summary

2. Global Home Healthcare Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. Average Pricing Analysis

5. Macro-Economic Indicators

6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix

8. Recent Development, Policies & Regulatory Landscape

9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. Global Home Healthcare Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological

11. Global Home Healthcare Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12. Global Home Healthcare Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Testing, Screening, & Monitoring Products, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Therapeutic Products, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Mobility Care Products, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Service: Market Share (2020-2030F)
12.3.1. Skilled Nursing Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Rehabilitation Therapy Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Hospice and Palliative Care Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Unskilled Care Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Respiratory Therapy Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Infusion Therapy Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Pregnancy Care Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Indication: Market Share (2020-2030F)
12.4.1. Cardiovascular Disorders & Hypertension, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Diabetes, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Respiratory Diseases, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Pregnancy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.5. Mobility Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.6. Hearing Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.7. Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.8. Wound Care, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.9. Other Indications, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13 Company Profile
13.1. Fresenius SE & Co. KGaA (Germany)
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. GE Healthcare (US)
13.3. Linde plc (Ireland)
13.4. F. Hoffmann-La Roche Ltd (Switzerland)
13.5. A&D Company (Japan)
13.6. BAYADA Home Health Care (US)
13.7. Invacare Corporation (US)
13.8. Abbott (US)
13.9. Amedisys (US)
13.10. Kindred at Home (US)
13.11. LHC Group, Inc. (US)
13.12. OMRON Corporation (Japan)
13.13. Koninklijke Philips N.V. (Netherlands)
13.14. Drive DeVilbiss Healthcare (US)
13.15. Hamilton Medical (Switzerland)
13.16. Other Prominent Players


14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.